Search Results for "complement inhibition"

GA in Practice

A panel of experts review real-world GA cases, imaging pearls, and practical guidance on starting complement inhibition earlier.

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

New Retina Radio Journal Club: Data in the Wake of COVID-19

Caroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; and Christina Weng, MD, MBA

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

The Tough: Declining Vision in an Age Before Anti-Complement Therapy

Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Take-Home Points for APL-2

David S. Boyer, MD

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

The Nuts and Bolts of GA Therapy: The Opening Sessions

Charles Wykoff, MD, PhD; with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD

The Nuts and Bolts of GA Therapy: Wrapping Up the Conversation

Charles Wykoff, MD, PhD; Sruthi Arepalli, MD; and Kenneth Fan, MD, MBA

View More